Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: ELUSYS THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2024-05-01 to 2027-04-30
Current total value of award: $69250063
Description: ANTHIM (OBILTOXAXIMAB)